Neurology
AHA/ASA Guideline for the management of patients with aneurysmal subarachnoid hemorrhage
29 May, 2023 | 11:16h | UTCTop Things to Know: 2023 Aneurysmal Subarachnoid Hemorrhage Guideline – American Heart Association
Commentary on Twitter
2023 Guideline for the Management of Patients With Aneurysmal Subarachnoid Hemorrhage: A Guideline From the American Heart Association/American Stroke Association https://t.co/IHZRkTR25t@American_Heart @American_Stroke @AHAScience @BrianHoh1 @drdangayach @CPDerdeyn pic.twitter.com/I2JdXnHuXp
— Stroke AHA/ASA (@StrokeAHA_ASA) May 23, 2023
RCT | Group support and skill-based learning reduce opioid use in chronic pain, but leads to no effect on pain perception
29 May, 2023 | 11:14h | UTCReducing Opioid Use for Chronic Pain With a Group-Based Intervention: A Randomized Clinical Trial – JAMA (free for a limited period)
See also: Visual Abstract
News Release: New treatment helps people stop addictive opioid painkillers used for chronic pain – University of Warwick
Guideline | Targeted temperature management in intracerebral, subarachnoid hemorrhage and acute ischemic stroke
29 May, 2023 | 10:48h | UTC
Advances and challenges in neuropathic pain: a narrative review and future directions
29 May, 2023 | 10:46h | UTC
Guideline | Assessment and early management of head injury
23 May, 2023 | 13:11h | UTCHead injury: assessment and early management – NICE
Commentary: NICE head injury guidelines 2023: Now who do we scan? – St Emilyn’s
M-A | Risk and benefits of wakefulness-promoting drugs in obstructive sleep apnea patients
23 May, 2023 | 12:43h | UTCComparative Efficacy and Safety of Wakefulness-Promoting Agents for Excessive Daytime Sleepiness in Patients With Obstructive Sleep Apnea: Systematic Review and Network Meta-analysis – Annals of Internal Medicine (link to abstract – $ for full-text)
News Release: Researchers find best treatment for excessive daytime sleepiness – McMaster University
Drug-induced abnormal involuntary movements: prevalence and treatment
22 May, 2023 | 13:30h | UTC
RCT | ART intensification shows no benefit in treating HIV-associated neurocognitive impairment
18 May, 2023 | 13:31h | UTC
Guideline | Acute dizziness and vertigo in the emergency department
15 May, 2023 | 13:25h | UTC
RCT | Cognitive behavioral therapy proves effective for severe post-COVID-19 fatigue
15 May, 2023 | 13:16h | UTCNews Release: Cognitive behavioral therapy lessens post-viral fatigue after COVID-19 – Amsterdam UMC
Commentary on Twitter
Efficacy of Cognitive Behavioral Therapy Targeting Severe Fatigue Following COVID-19: Results of a Randomized Controlled Trial
✅ Just Accepted
🔓 Open Access@amsterdamUMChttps://t.co/P1jwLOcfvw— Clinical Infectious Diseases (@CIDJournal) May 13, 2023
RCT | Neck–shoulder region training for chronic headache in women
15 May, 2023 | 12:59h | UTC
Commentary on Twitter
Neck-Shoulder Region Training for Chronic Headache in Women: A Randomized Controlled Trial
👀👀👇👇
"The progressive exercise program almost halved headache frequency"https://t.co/HQN2yppF27 pic.twitter.com/3ZFltwJTWl
— Physio Meets Science (@PhysioMeScience) April 26, 2023
M-A | Endovascular therapy for stroke presenting beyond 24 hours
12 May, 2023 | 13:44h | UTC
Commentary on Twitter
Endovascular therapy for stroke presenting at >24 hours was associated with favorable clinical, safety, and procedural outcomes in this meta-analysis of 569 patients. https://t.co/DjoDDcr1mf
— JAMA Network Open (@JAMANetworkOpen) May 4, 2023
Should my elderly hospitalized patient with acute onset of altered mental status undergo stat head CT?
12 May, 2023 | 13:38h | UTC
Ear-related balance disorders: evidence and resources
11 May, 2023 | 12:14h | UTCEar-related balance disorders: evidence and resources – Evidently Cochrane
RCT | Safety and efficacy of zilucoplan in patients with generalized myasthenia gravis
11 May, 2023 | 12:04h | UTCSafety and efficacy of zilucoplan in patients with generalised myasthenia gravis (RAISE): a randomised, double-blind, placebo-controlled, phase 3 study – The Lancet Neurology (link to abstract – $ for full-text)
News Release: Researchers report on rozanolixizumab, zilucoplan phase 3 myasthenia gravis study – MedicalXpress
SR | Perampanel add‐on for drug‐resistant focal epilepsy
11 May, 2023 | 11:55h | UTCPerampanel add‐on for drug‐resistant focal epilepsy – Cochrane Library
Summary: Perampanel add-on for drug-resistant focal epilepsy – Cochrane Library
Commentary on Twitter
💊 Perampanel add‐on for drug‐resistant focal #epilepsy
📚 Evidence from 7 trials involving 2,524 participants
"…effective @ reducing seizure frequency & may maintain seizure freedom…Perampanel is well‐tolerated at doses of 8 mg/day or less."https://t.co/LSJoYeDi8S— The Cochrane Library (@CochraneLibrary) April 17, 2023
M-A | Association of SARS-CoV-2 vaccination or infection with Bell palsy
10 May, 2023 | 16:03h | UTC
Review | Early switch to oral antimicrobials in brain abscess
10 May, 2023 | 15:55h | UTC
Cohort Study | Predicting the emergence of malignant brain edema in acute ischemic stroke
10 May, 2023 | 15:26h | UTC
Review | Estimating risk of antidepressant withdrawal from a review of published data
9 May, 2023 | 14:39h | UTCEstimating Risk of Antidepressant Withdrawal from a Review of Published Data – CNS Drugs
Commentary: Researchers Identify Factors to Predict Risk of Antidepressant Withdrawal – Mad in America
M-A | Adverse events of cannabidiol use in patients with epilepsy
9 May, 2023 | 14:30h | UTC
M-A | Endovascular vs. medical management of acute basilar artery occlusion
8 May, 2023 | 12:44h | UTCRelated:
AHA/ASA Scientific Statement | Cognitive impairment after ischemic and hemorrhagic stroke
5 May, 2023 | 15:36h | UTCNews Release: Cognitive impairment after stroke is common, and early diagnosis and treatment needed – American Heart Association
Commentary on Twitter
Cognitive Impairment After Ischemic and Hemorrhagic Stroke: A Scientific Statement From the American Heart Association/American Stroke Association https://t.co/YWNHZVaXnl@nsanar @ST_Pendlebury @hugoapariciomd @gottesman_lab @VCI_EricSmith @AHAScience pic.twitter.com/HdeoC0bNdm
— Stroke AHA/ASA (@StrokeAHA_ASA) May 1, 2023
Scoping review of rational polytherapy in patients with drug-resistant epilepsy
4 May, 2023 | 13:50h | UTCScoping review of rational polytherapy in patients with drug-resistant epilepsy – Pharmacotherapy
SR | Perampanel add‐on for drug‐resistant focal epilepsy
4 May, 2023 | 13:49h | UTCPerampanel add‐on for drug‐resistant focal epilepsy – Cochrane Library
Summary: Perampanel add-on for drug-resistant focal epilepsy – Cochrane Library